Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Among 169,649 patients with MASLD, GLP-1 receptor agonist initiation was linked to significantly lower probability of incident cirrhosis [adjusted hazard ratio (aHR): 0.86, 95%CI: 0.80-0.93], hepatic decompensation (aHR: 0.77, 95%CI: 0.65-0.90), and hepatocellular carcinoma (HCC) (aHR: 0.79, 95%CI: 0.68-0.92) over a median follow-up of 3.5 years compared to non-users
Real-world patient-language layer recurring themes and vocabulary drawn from the tirzepatide Reddit communities (r/Zepbound, r/Mounjaro, r/tirzepatide and related), read for theme prominence and the words users use, not for incidence
Do they work for you
Always follow the label instructions, and discontinue use if any adverse reaction occurs.
US$ 20.39
US$ 24.57
US$ 19.98
US$ 27.57
US$ 25.89
US$ 20.73
